Treating Methamphetamine-Associated PAH: The Missing Piece in Patient Care
John Kingrey, MD
Recognizing Pulmonary Hypertension in Interstitial Lung Disease
Jean M. Elwing, MD, FCCP
Rethinking PH-ILD: What Emerging Data Could Mean for Patient Care
Don’t Miss the Opportunity to Address Persistent CV Risk: Optimizing Outcomes for Ambulatory Patients With HFrEF and LVEF <45%
Robert J. Mentz, MD, FHFSA, FACC
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
Nosheen Reza, MD
Anjali Tiku Owens, MD
Pieter Martens, MD, MSc, PhD
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
From Evidence to Action: Advancing Care in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome
Dr. Ioanna Gouni-Berthold, MD
Gerald Watts, MD, PhD
Refining Nuclear Scintigraphy for ATTR-CM Diagnosis
Mary Leuchars, MD
Saurabh Malhotra, MD, MPH, FASNC
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Examining the Link Between Surgical Menopause and Heart Failure
Elise Shalowitz, MS
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Heart Transplant in ATTR-CM: A New Look at Referral and Candidacy
Steve Jackson, PharmD
Alex Reyentovich, MD
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.